403
Participants
Start Date
September 25, 2019
Primary Completion Date
June 9, 2022
Study Completion Date
AC Camargo, São Paulo
Collaborators (1)
AstraZeneca
INDUSTRY
Latin American Cooperative Oncology Group
OTHER